Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

<p>Supplementary Figure 1: Study flow-chart. Supplementary Figure 2: Kaplan-Meier curves of event-free survival according to tertile-split tumor mutational burden. Supplementary Figure 3. Kaplan-Meier curves of recurrence-free survival according to the molecular subtype. Supplementary Figure 4...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Giuseppe Basile (15051269) (author)
Otros Autores: Marco Bandini (15051272) (author), Ewan A. Gibb (15051275) (author), Jeffrey S. Ross (15030824) (author), Daniele Raggi (15051278) (author), Laura Marandino (15051281) (author), Tiago Costa de Padua (15051284) (author), Emanuele Crupi (15051287) (author), Renzo Colombo (15051290) (author), Maurizio Colecchia (15051293) (author), Roberta Lucianò (15051296) (author), Luigi Nocera (15051299) (author), Marco Moschini (15051302) (author), Alberto Briganti (15051305) (author), Francesco Montorsi (15051308) (author), Andrea Necchi (15044772) (author)
Publicado: 2025
Materias:
Cancer
Immuno-oncology
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Genitourinary Cancers
Bladder cancer
Immunotherapy
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:<p>Supplementary Figure 1: Study flow-chart. Supplementary Figure 2: Kaplan-Meier curves of event-free survival according to tertile-split tumor mutational burden. Supplementary Figure 3. Kaplan-Meier curves of recurrence-free survival according to the molecular subtype. Supplementary Figure 4: PD-L1 staining values (CPS percentages) according to molecular subtypes, split by the three subtyping classifiers GSC/Decipher, Consensus classification, and TCGA.</p>

Ejemplares similares